Obesity-Associated Metabolic Disturbances Reverse the Antioxidant and Anti-Inflammatory Properties of High-Density Lipoproteins in Microglial Cells.

dc.contributor.authorGrao-Cruces, Elena
dc.contributor.authorMillan-Linares, Maria C
dc.contributor.authorMartin-Rubio, Maria E
dc.contributor.authorToscano, Rocio
dc.contributor.authorBarrientos-Trigo, Sergio
dc.contributor.authorBermudez, Beatriz
dc.contributor.authorMontserrat-de la Paz, Sergio
dc.date.accessioned2025-01-07T15:22:21Z
dc.date.available2025-01-07T15:22:21Z
dc.date.issued2021-11-19
dc.description.abstractHigh-density lipoproteins (HDLs) play an important role in reverse cholesterol transport and present antioxidant properties, among others. In the central nervous system (CNS), there are HDLs, where these lipoproteins could influence brain health. Owing to the new evidence of HDL functionality remodeling in obese patients, and the fact that obesity-associated metabolic disturbances is pro-inflammatory and pro-oxidant, the aim of this study was to investigate if HDL functions are depleted in obese patients and obesity-associated microenvironment. HDLs were isolated from normal-weight healthy (nwHDL) and obese men (obHDL). The oxHDL level was measured by malondialdehyde and 4-hydroxynoneal peroxided products. BV2 microglial cells were exposed to different concentrations of nwHDL and obHDL in different obesity-associated pro-inflammatory microenvironments. Our results showed that hyperleptinemia increased oxHDL levels. In addition, nwHDLs reduced pro-inflammatory cytokines' release and M1 marker gene expression in BV2 microglial cells. Nevertheless, both nwHDL co-administered with LPS+leptin and obHDL promoted BV2 microglial activation and a higher pro-inflammatory cytokine production, thus confirming that obesity-associated metabolic disturbances reverse the antioxidant and anti-inflammatory properties of HDLs in microglial cells.
dc.identifier.doi10.3390/biomedicines9111722
dc.identifier.issn2227-9059
dc.identifier.pmcPMC8615358
dc.identifier.pmid34829950
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8615358/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2227-9059/9/11/1722/pdf?version=1637311561
dc.identifier.urihttps://hdl.handle.net/10668/27080
dc.issue.number11
dc.journal.titleBiomedicines
dc.journal.titleabbreviationBiomedicines
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectlipoproteins
dc.subjectmicroglia
dc.subjectneuroinflammation
dc.subjectobesity
dc.subjectoxidation
dc.subjectparaoxonase
dc.titleObesity-Associated Metabolic Disturbances Reverse the Antioxidant and Anti-Inflammatory Properties of High-Density Lipoproteins in Microglial Cells.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number9

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8615358.pdf
Size:
1.67 MB
Format:
Adobe Portable Document Format